Back to search

Article

<i>In vivo</i> intra-uterine delivery of TAT-fused Cre recombinase and CRISPR/Cas9 editing unveil histopathology of Pten/p53-deficient endometrial cancers

2023-06-08

Abstract excerpt

<h4>ABSTRACT</h4> Pten and p53 are two of the most frequently mutated tumor suppressor genes in endometrial cancer. However, the functional consequences and histopathological manifestation of concomitant p53 and Pten loss of function alterations in the development of endometrial cancer is still controversial. Here, we demonstrate that simultaneous Pten and p53 deletion is sufficient to cause epithelial to mesench...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f9aa71b-f10d-5087-95b2-adc26e9f6cff
DOI
10.1101/2023.06.08.544224
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vivo</i> intra-uterine delivery of TAT-fused Cre recombinase and CRISPR/Cas9 editing unveil histopathology of Pten/p53-deficient endometrial cancersDOI 10.1101/2023.06.08.544224
Select a neighboring publication to make it the new centre.